Certara CERT Stock
Certara Price Chart
Certara CERT Financial and Trading Overview
| Certara stock price | 11.63 USD |
| Previous Close | 10.54 USD |
| Open | 10.63 USD |
| Bid | 9.3 USD x 200 |
| Ask | 10.94 USD x 200 |
| Day's Range | 10.09 - 10.69 USD |
| 52 Week Range | 8.64 - 16.61 USD |
| Volume | 1.22M USD |
| Avg. Volume | 1.85M USD |
| Market Cap | 1.64B USD |
| Beta (5Y Monthly) | 1.448 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.05 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.78 USD |
CERT Valuation Measures
| Enterprise Value | 2.03B USD |
| Trailing P/E | N/A |
| Forward P/E | 20.2 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.1535406 |
| Price/Book (mrq) | 1.5040953 |
| Enterprise Value/Revenue | 5.138 |
| Enterprise Value/EBITDA | 20.662 |
Trading Information
Certara Stock Price History
| Beta (5Y Monthly) | 1.448 |
| 52-Week Change | -39.083% |
| S&P500 52-Week Change | 13.16% |
| 52 Week High | 16.61 USD |
| 52 Week Low | 8.64 USD |
| 50-Day Moving Average | 11.33 USD |
| 200-Day Moving Average | 11.56 USD |
CERT Share Statistics
| Avg. Volume (3 month) | 1.85M USD |
| Avg. Daily Volume (10-Days) | 1.65M USD |
| Shares Outstanding | 162.23M |
| Float | 121.84M |
| Short Ratio | 5.61 |
| % Held by Insiders | 2.48% |
| % Held by Institutions | 100.90% |
| Shares Short | 8.96M |
| Short % of Float | 7.30% |
| Short % of Shares Outstanding | 5.51% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | March 31, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | -0.66% |
| Operating Margin (ttm) | 7.19% |
| Gross Margin | 60.25% |
| EBITDA Margin | 24.86% |
Management Effectiveness
| Return on Assets (ttm) | 1.12% |
| Return on Equity (ttm) | -0.24% |
Income Statement
| Revenue (ttm) | 394.5M USD |
| Revenue Per Share (ttm) | 2.45 USD |
| Quarterly Revenue Growth (yoy) | 9.70% |
| Gross Profit (ttm) | 237.72M USD |
| EBITDA | 98.09M USD |
| Net Income Avi to Common (ttm) | -2625000 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 180.51M USD |
| Total Cash Per Share (mrq) | 1.11 USD |
| Total Debt (mrq) | 309.17M USD |
| Total Debt/Equity (mrq) | 28.51 USD |
| Current Ratio (mrq) | 2.777 |
| Book Value Per Share (mrq) | 6.715 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 93.52M USD |
| Levered Free Cash Flow (ttm) | 71.36M USD |
Profile of Certara
| Country | United States |
| State | PA |
| City | Radnor |
| Address | 4 Radnor Corporate Center |
| ZIP | 19087 |
| Phone | 415 237 8272 |
| Website | https://www.certara.com |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 1487 |
Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.
Q&A For Certara Stock
What is a current CERT stock price?
Certara CERT stock price today per share is 11.63 USD.
How to purchase Certara stock?
You can buy CERT shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Certara?
The stock symbol or ticker of Certara is CERT.
Which industry does the Certara company belong to?
The Certara industry is Health Information Services.
How many shares does Certara have in circulation?
The max supply of Certara shares is 160.62M.
What is Certara Price to Earnings Ratio (PE Ratio)?
Certara PE Ratio is 232.60000000 now.
What was Certara earnings per share over the trailing 12 months (TTM)?
Certara EPS is 0.05 USD over the trailing 12 months.
Which sector does the Certara company belong to?
The Certara sector is Healthcare.
Certara CERT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23724.96 USD — |
+0.61
|
9.88B USD — | 23628.82 USD — | 23946.23 USD — | — - | 9.88B USD — |
| US Tech US 700 Small Cap Index NQUS700SC | 2566.34 USD — |
+0.47
|
— — | 2546.3 USD — | 2571.79 USD — | — - | — — |
| US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG | 3514.71 USD — |
+0.87
|
— — | 3485.13 USD — | 3527.41 USD — | — - | — — |
| US Tech Health Care IXHC | 1115.96 USD — |
+0.87
|
— — | 1099.74 USD — | 1117.62 USD — | — - | — — |
| US Tech Global Select Market Com NQGS | 11620.1 USD — |
+0.59
|
— — | 11575.56 USD — | 11733.88 USD — | — - | — — |
- {{ link.label }} {{link}}


